Cargando…
Molecular Approaches to Treating Pediatric Leukemias
Over the past decades, striking progress has been made in the treatment of pediatric leukemia, approaching 90% overall survival in children with acute lymphoblastic leukemia (ALL) and 75% in children with acute myeloid leukemia (AML). This has mainly been achieved through multiagent chemotherapy inc...
Autores principales: | Kuhlen, Michaela, Klusmann, Jan-Henning, Hoell, Jessica I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742719/ https://www.ncbi.nlm.nih.gov/pubmed/31555628 http://dx.doi.org/10.3389/fped.2019.00368 |
Ejemplares similares
-
RNA-Binding Proteins in Acute Leukemias
por: Schuschel, Konstantin, et al.
Publicado: (2020) -
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
por: Schmidt, Franziska, et al.
Publicado: (2022) -
Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022) -
Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022) -
Advance care planning and outcome in pediatric palliative home care
por: Hoell, Jessica I., et al.
Publicado: (2018)